Early treatment to slow or even halt the progression of multiple sclerosis raises new hope for patients but poses challenges in clinical decision-making, according to Professor Bill Carroll, scientific chariman of MS Research Australia.
Speaking at the Annual Scientific Meeting of the Australian and New Zealand Association of Neurologists in Hobart, Professor Carroll said the management of MS was moving to a new level of complexity.... Read More - http://tinyurl.com/LatestMSNews
